| BXMYX | SMSAX | BXMYX / SMSAX | |
| Total Expense Ratio | 3.75 | 2.18 | 172% |
| Annual Report Gross Expense Ratio | 3.75 | 2.93 | 128% |
| Fund Existence | 11 years | 16 years | - |
| Gain YTD | 4.495 | 7.329 | 61% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 3.73B | 241M | 1,549% |
| Annual Yield % from dividends | 5.41 | 4.75 | 114% |
| Returns for 1 year | 10.70 | 15.07 | 71% |
| Returns for 3 years | 29.03 | 33.69 | 86% |
| Returns for 5 years | 22.55 | 19.46 | 116% |
| Returns for 10 years | 44.36 | 40.36 | 110% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LFSC | 42.60 | 0.22 | +0.52% |
| F/m Emerald Life Sciences Innovation ETF | |||
| DVAL | 15.61 | 0.02 | +0.14% |
| BrandywineGLOBAL Dyn US Lrg Cap Val ETF | |||
| HYBB | 46.62 | -0.01 | -0.02% |
| iShares BB Rated Corporate Bond ETF | |||
| TFI | 45.61 | -0.06 | -0.13% |
| Stt Strt® SPDR® Nuveen ICE Muncpl ETF | |||
| DDFJ | 19.63 | -0.13 | -0.66% |
| Innovator Eq Dual Drctnl 15 Buff ETF-Jan | |||